Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insights into hepatitis C.

D M Forton1, M Wright, S Knapp

  • 1Department of Medicine A, Imperial College and Liver Centre, St Mary's Hospital, London.

Clinical Medicine (London, England)
|January 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2022
Same author

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2021
Same author

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.

Journal of clinical and experimental hepatology·2019
Same author

Genetic variation in GABRβ1 and the risk for developing alcohol dependence.

Psychiatric genetics·2017
Same author

Hepatitis E virus infection and acute-on-chronic liver failure in West Africa: a case-control study from The Gambia.

Alimentary pharmacology & therapeutics·2015
Same journal

Can hepatology lead the way? Synthesising current global curricula and proposing a model for an international speciality curriculum.

Clinical medicine (London, England)·2026
Same journal

Prognostic value of C-reactive protein to albumin ratio (CAR) for mortality in older adults with sepsis: cohort study.

Clinical medicine (London, England)·2026
Same journal

Letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
Same journal

Finerenone Exposure and Ischemic Stroke in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Clinical medicine (London, England)·2026
Same journal

Prevalence and predictive factors of chronic kidney disease among individuals with cardiometabolic risk factors: A multicenter cross sectional study, North East Ethiopia.

Clinical medicine (London, England)·2026
Same journal

Authors' response to Dr Lucy Williams' letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
See all related articles

Hepatitis C infection often persists due to immune evasion and weak T cell responses. Genetic factors and viral characteristics influence disease severity and antiviral treatment resistance, potentially involving the central nervous system.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection presents complex challenges in management.
  • Understanding host-virus interactions is crucial for effective treatment strategies.

Purpose of the Study:

  • To elucidate the key features of Hepatitis C infection.
  • To explore the interplay between host genetics, viral factors, and disease outcomes.
  • To investigate mechanisms of antiviral resistance and viral persistence.

Main Methods:

  • Analysis of immune responses, including T cell responsiveness.
  • Examination of host genetic polymorphisms in immune and fibrosis pathways.
  • Assessment of viral characteristics and immune escape mechanisms.
  • Review of antiviral therapy resistance patterns.

Related Experiment Videos

Main Results:

  • HCV exhibits high viral persistence driven by impaired T cell immunity and viral immune escape.
  • Significant inter-individual variation in liver damage (fibrosis, cirrhosis) is linked to host genetics and viral factors.
  • HCV demonstrates considerable resistance to antiviral therapies, with mechanisms mirroring those of viral persistence.

Conclusions:

  • Hepatitis C infection is characterized by persistent viremia, variable end-organ damage, and treatment resistance.
  • Host genetic factors and viral attributes critically shape disease progression and therapeutic response.
  • The potential for HCV to infect immunologically privileged sites, like the CNS, warrants further investigation.